MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14737140.2020.1822743

Медицинская библиотека · Expert review of anticancer therapy · 2020

Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer.

Moussa Mohamad, Papatsoris Athanasios G, Dellis Athanasios, Abou Chakra Mohamed, Saad Wajih

СтатьяОбзорПеревод в очереди

Аннотация

INTRODUCTION

Many patients with non-muscle-invasive bladder cancer (NMIBC) failed intravesical BCG therapy. Currently, radical cystectomy is the recommended standard of care for those patients. There is unfortunately no effective other second-line therapy recommended.

AREAS COVERED: In this review, we present the topics of BCG unresponsive NMIBC; definition, prognosis, and further treatment options: immunotherapy, intravesical chemotherapy, gene therapy, and targeted individualized therapy.

EXPERT OPINION: There are major challenges of the management of NMIBC who failed BCG therapy as many patients refuse or are unfit for radical cystectomy. Multiple new modalities currently under investigation in ongoing clinical trials to better treat this category of patients. Immunotherapy, especially PD-1/PD-L1 inhibitors, offers exciting and potentially effective strategies for the treatment of BCG unresponsive NMIBC. As the data expands, it is sure that soon there will be established new guidelines for NMIBC.

Для цитирования: Moussa Mohamad, Papatsoris Athanasios G, Dellis Athanasios, Abou Chakra Mohamed, Saad Wajih. Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer.. Expert review of anticancer therapy. 2020. DOI: 10.1080/14737140.2020.1822743.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.